Search

During UV disinfection, the required UV dose in terms of fluence depends upon the species of bacteria spore and protozoa. To rank their UV disinfection sensitivity, spore sensitivity index (SPSI) and protozoan sensitivity index (PSI) are defined. For spores, shoulder effect exists, therefore, SPSI is defined as the ratio between the ki of any spores for the linear portion of the dose response curve to the kir of Bacillus subtilis as the reference spore. After statistical analysis, the fluence of any spore can be predicted by SPSI through equation, H = (0.8358 ± 0.126)*LogI*SPSI + H0. PSI is defined as the ratio between the inactivation rate constants of a protozoa in reference to that of Cryptosporidium parvum. The equation predicting the fluence of any protozoa in reference to Cryptosporidium parvum is: H = 107.45*(3.86 ± 2.68)*LogI/PSI. Two regression equations suggest that protozoa require significantly higher UV dose than bacteria spores. HIGHLIGHTS UV sensitivity index of bacteria spore and protozoa were defined.; The UV fluence could be predicted by the UV sensitivity indexes.; Protozoa required significantly higher UV dose than that required by spores.;

Abstract Small cell lung cancer (SCLC) remains a deadly form of cancer, with a 5-year survival rate of less than 10 percent, necessitating novel therapies. Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is an oncofetal protein that is emerging as a therapeutic target and is co-expressed with BCL2 in multiple tumor types due to microRNA coregulation. We hypothesize that ROR1-targeted therapy is effective in small cell lung cancer and synergizes with therapeutic BCL2 inhibition. Tissue microarrays (TMAs) and formalin-fixed paraffin-embedded (FFPE) SCLC patient samples were utilized to determine the prevalence of ROR1 and BCL2 expression in SCLC. Eight SCLC-derived cell lines were used to determine the antitumor activity of a small molecule ROR1 inhibitor (KAN0441571C) alone and in combination with the BCL2 inhibitor venetoclax. The Chou-Talalay method was utilized to determine synergy with the drug combination. ROR1 and BCL2 protein expression was identified in 93% (52/56) and 86% (48/56) of SCLC patient samples, respectively. Similarly, ROR1 and BCL2 were shown by qRT-PCR to have elevated expression in 79% (22/28) and 100% (28/28) of SCLC patient samples, respectively. KAN0441571C displayed efficacy in 8 SCLC cell lines, with an IC50 of 500 nM or less. Synergy as defined by a combination index of

Introducción: El traumatismo vascular constituye una entidad de importancia en los servicios de emergencia por su alta incidencia de complicaciones. Objetivo: Caracterizar el traumatismo vascular en un hospital de segundo nivel de Ecuador durante el periodo julio 2017-julio 2020. Material y métodos: Se realizó un estudio descriptivo, transversal y correlacional que incluyó 45 pacientes. Se calcularon medidas de tendencia central como media y desviación estándar de la variable cuantitativa edad, así como las frecuencias absolutas y relativas para las demás variables. Resultados: Predominaron los jóvenes de sexo masculino. Resultó más frecuente el trauma penetrante por arma blanca y accidentes de tránsito. La mayoría de los diagnósticos se realizó por sospecha clínica. La técnica quirúrgica de mayor empleo fue la revascularización con vena safena invertida en trece pacientes. Conclusiones: Predominaron los traumatismos vasculares de arteria humeral por mecanismos penetrantes en jóvenes de sexo masculino y de procedencia urbana, solucionados por revascularización con vena safena.

Mutations in the retinoblastoma (RB) tumour suppressor pathway are a hallmark of cancer and a prevalent feature of lung adenocarcinoma.sup.1-3. Although RB was the first tumour suppressor to be identified, the molecular and cellular basis that underlies selection for persistent RB loss in cancer remains unclear.sup.4-6. Methods that reactivate the RB pathway using inhibitors of cyclin-dependent kinases CDK4 and CDK6 are effective in some cancer types and are currently under evaluation for the treatment of lung adenocarcinoma.sup.7-9. Whether RB pathway reactivation will have therapeutic effects and whether targeting CDK4 and CDK6 is sufficient to reactivate RB pathway activity in lung cancer remains unknown. Here we model RB loss during lung adenocarcinoma progression and pathway reactivation in established oncogenic KRAS-driven tumours in mice. We show that RB loss enables cancer cells to bypass two distinct barriers during tumour progression. First, RB loss abrogates the requirement for amplification of the MAPK signal during malignant progression. We identify CDK2-dependent phosphorylation of RB as an effector of MAPK signalling and critical mediator of resistance to inhibition of CDK4 and CDK6. Second, RB inactivation deregulates the expression of cell-state-determining factors, facilitates lineage infidelity and accelerates the acquisition of metastatic competency. By contrast, reactivation of RB reprograms advanced tumours towards a less metastatic cell state, but is nevertheless unable to halt cancer cell proliferation and tumour growth due to adaptive rewiring of MAPK pathway signalling, which restores a CDK-dependent suppression of RB. Our study demonstrates the power of reversible gene perturbation approaches to identify molecular mechanisms of tumour progression, causal relationships between genes and the tumour suppressive programs that they control and critical determinants of successful cancer therapy. Loss of RB promotes both malignant progression and the development of metastatic disease; however, whereas reactivation of the RB pathway can revert metastatic tumour cell states to non-metastatic cell states, malignant cell proliferation is supported by MAPK-CDK2-dependent suppression of RB., Author(s): David M. Walter [sup.1] [sup.2] , Travis J. Yates [sup.1] , Miguel Ruiz-Torres [sup.1] , Caroline Kim-Kiselak [sup.1] , A. Andrea Gudiel [sup.1] , Charuhas Deshpande [sup.3] [sup.4] , [...]

Micro-sieving is an effective way to prevent organic pollutants enter the main biological process and reduce aeration intensity and sludge production. However, few researchers quantified the effect of micro-sieving on meat processing wastewater treatment. The current study developed Excel-based models to compare the energy consumption and production of historical, conventional and innovative systems. Historical and conventional systems employ activated sludge (AS), nitrification, and denitrification as the main biological processes. Innovative systems are designed by using up-flow anaerobic sludge blanket (UASB) and partial nitrification/Anammox (PN/A) as the main treatment processes. Results show that the CH4/O2 energy ratios of the innovative treatment system are as high as 10 times of the historical and conventional systems. Therefore, innovative system can achieve electrical self-sufficiency. Micro-sieving reduces 5% of aeration demand. Furthermore, the impact of micro-sieving on the innovative treatment systemis assessed by cost-benefit analysis. System with micro-sieving has the shortest payback time of 2.1 years and reduces cost of the innovative treatment system. An excel-based model was developed to quantify the impact of micro-sieving on energy and cost of innovative treatment system, thereby providing a valuable reference for future sustainable engineering design of meat processing wastewater treatment. [ABSTRACT FROM AUTHOR]